Symbol
ELVN on Nasdaq
Investment type
Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned
3,226,331 shares
Security Ownership %
5.4%

Venrock Healthcare Capital Partners III, L.P. ownership in Enliven Therapeutics, Inc. Common Stock, par value $0.001 per share (ELVN)

14 Nov 2025 - Venrock Healthcare Capital Partners III, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,226,331 shares of Enliven Therapeutics, Inc. Common Stock, par value $0.001 per share (ELVN). This represents 5.4% ownership of the company. This is the first filing by Venrock Healthcare Capital Partners III, L.P. disclosing ownership of Enliven Therapeutics, Inc. Common Stock, par value $0.001 per share (ELVN).